Keyphrases
Food Allergy
94%
Omalizumab
61%
Peanut
50%
Peanut Allergy
40%
Sublingual Immunotherapy
36%
Oral Immunotherapy
36%
Food Allergens
26%
High-risk Infants
23%
Socioeconomic Factors
18%
Drug Allergy
18%
Serology
18%
Multiple Food Allergy
18%
Food Allergy Diagnosis
18%
Eczema Severity
18%
Area under the Curve
18%
Food Allergy Prevention
18%
Skin Prick Test
18%
CTLA-4 Insufficiency
18%
Ara h 2
18%
Patient-Reported Outcomes Measurement Information System (PROMIS)
18%
Unmet Needs
18%
Diagnostic Accuracy
18%
Food Allergy Immunotherapy
18%
Serum IgE
18%
Anti-IgE Therapy
18%
Allergic Diseases
18%
Clinical Trials
16%
Oral Food Challenge
16%
Milk
14%
Monotherapy
14%
Allergic Rhinitis
13%
Trial Design
12%
Adverse Events
12%
Peanut Protein
11%
Allergy
10%
Cashew
10%
Placebo
10%
Working Diagnosis
9%
Inborn Errors of Immunity
9%
Management Education
9%
Health Outcomes
9%
Protocol Study
9%
Treatment Strategy
9%
Rapidly Evolving
9%
Clinical Significance
9%
Health Inequities
9%
Socioeconomic Disparities
9%
Futures Past
9%
Medical Health
9%
Accidental Exposure
9%
Immunology and Microbiology
Food Allergy
95%
Immunotherapy
67%
Allergen Immunotherapy
57%
Omalizumab
54%
Peanut Allergy
54%
Eczema
43%
Infancy
36%
Immunoglobulin E
31%
Atopic Dermatitis
31%
Food Allergen
28%
Asthma
26%
Allergic Rhinitis
24%
Sensitization
22%
Cow
21%
Milk Allergy
20%
Prevalence
20%
Epitope
18%
Serology
18%
Immunopathology
18%
Mouse
18%
T Cell
18%
Adjuvant
18%
Primary Immunodeficiency
18%
FOXP3
11%
Hypersensitive Response
9%
Allergen
8%
Atopy
7%
Hypersensitivity
6%
Medicine and Dentistry
Food Allergy
100%
Immunoglobulin E
47%
Sensitization
22%
Atopic Dermatitis
20%
Patient-Reported Outcome
18%
Immunoglobulin Antibody
18%
Disease
18%
Childbirth
18%
Eczema
18%
CTLA-4
18%
Diagnostic Accuracy
18%
Skin Test
18%
Drug Intolerance
18%
Oral Immunotherapy
15%
Health Care
14%
Asthma
12%
Cytopenia
12%
Abatacept
12%
Prevalence
11%
Allergic Response
9%
Adolescent
9%
Health Care Disparity
9%
Drug Therapy
9%
Public Health
9%
Immunopathology
9%
Primary Immunodeficiency
9%
Allergic Rhinitis
9%
Health Care Outcome
9%
Diagnosis
8%
Infection
8%
Atopy
7%
Monotherapy
6%
Prick Test
6%
Germline Mutation
6%
Disease Severity
6%
Regulatory T Cell
6%
Avoidance Response
6%
Stem Cell Therapy
6%
Adverse Event
6%
Allogeneic Hematopoietic Stem Cell Transplantation
6%
Clinical Feature
6%
Egg Allergy
6%
Sublingual Immunotherapy
6%
Immunoglobulin
6%
Immunosuppressant
6%
Rituximab
6%
Gut
6%
Central Nervous System
6%
DNA Vaccine
6%
Splenectomy
6%